Recent ALT Stock Price | ALT Stock Predictions | |
$6.58 | +217.48% |
$20.89 |
Recent ALT Analyst Ratings Breakdown, Making ALT Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 8 | 7 | 6 | 6 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 2 | 2 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.4 | 1.44 | 1.5 | 1.5 |
For the ALT stock predictions from the analysts covering Altimmune Inc, we have collected all of the individual ALT stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 9 different analysts covering ALT (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ALT stock predictions may vary widely, another useful metric to consider is the median ALT stock prediction, which represents the price at which half of the analysts
made ALT stock predictions that were higher and half made ALT stock predictions that were lower. This makes for a different take on the ALT stock predictions out there, as compared to average or mean.
And that median across all the individual ALT stock predictions was: $24.0 as of 2025-01-16.
The very highest of the ALT stock predictions for one year price target was $28.0, while the very lowest of the ALT stock predictions in the analyst group was
$10.0 (with a standard deviation of $6.392). Get the latest Zacks research report on ALT — FREE
Find out: ALT next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
VXRT Stock Predictions
HSY Stock Predictions
CEQP Stock Predictions
GLOP Stock Predictions
HMC Stock Predictions
LAND Stock Predictions
QRVO Stock Predictions
GNTY Stock Predictions
NMIH Stock Predictions
|
|
Strong Buy (3.60 out of 4) 65th percentile
(ranked higher than approx. 65% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |